Agrenvec
PrivateLast Round
Grant
Feb 26, 2025
Total Funding Raised
$1.26M
Company Overview
Agrenvec operates in Healthcare & Life Sciences and is based in Madrid. Its latest recorded funding round was a Grant round in February 2025.
Agrenvec is a biotechnology company that specializes in the plant-based manufacturing of high-quality recombinant human proteins for skincare, diagnostics, research, and biotechnological applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Agrenvec Comparables
Compare Agrenvec with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Leaf Expression Systems | 88% | |
| ORF Genetics | 88% | |
| Cape Bio Pharms | 86% |
For institutional investors. Book with your work email.
Agrenvec Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 26, 2025 | ||||
| Grant | Dec 30, 2022 | ||||
| Series A | Apr 27, 2010 |
For institutional investors. Book with your work email.
Agrenvec Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AXIS Participaciones Empresariales | Series A |
| European Union NextGenerationEU | Grant |
| Criteria Capital Risc | Series A |
| Center for Technological Development and Innovation | Grant |
Agrenvec Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Agrenvec's valuation, stock price, and market status.
Is Agrenvec a public or private company?
Agrenvec is a private company.
What is the current stock price of Agrenvec?
Agrenvec is a private company, so its shares have no public market price. Caplight tracks Agrenvec's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Agrenvec worth (valuation)?
Valuation information for Agrenvec is not publicly available.
Can I buy Agrenvec stock?
Agrenvec shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Agrenvec's last funding round?
Agrenvec's most recent funding round was Grant on February 26, 2025.
Who are the main investors in Agrenvec?
Key investors in Agrenvec include AXIS Participaciones Empresariales, European Union NextGenerationEU, Criteria Capital Risc, Center for Technological Development and Innovation.
Will Agrenvec IPO soon?
No public IPO plans have been announced for Agrenvec.
How can I track Agrenvec secondary market activity?
Caplight tracks bids, offers, and trades in Agrenvec's shares on secondary markets.